Monitor executive leadership turnover across all C-suite and senior management roles — CEO, CFO, COO, CTO, CMO, General Counsel, and more. TrackSuccession combines SEC 8-K filings with press release monitoring to capture the full picture of executive changes at public companies.
Executive turnover data helps investors assess management stability, recruiters identify placement opportunities, and analysts track industry-wide leadership trends. Filter by role, sector, company size, and date range.
| Company | Ticker | Executive | Role | Type | Date |
|---|---|---|---|---|---|
| AUTOZONE INC | AZO | Claire R. McDonough | Director | departure | 2026-10-09 |
| Moleculin Biotech, Inc. | MBRX | Walter V. Klemp | Director | appointment | 2026-10-09 |
| Moleculin Biotech, Inc. | MBRX | Robert E. George | Director | appointment | 2026-10-09 |
| Moleculin Biotech, Inc. | MBRX | Michael D. Cannon | Director | appointment | 2026-10-09 |
| Moleculin Biotech, Inc. | MBRX | John Climaco | Director | appointment | 2026-10-09 |
| Moleculin Biotech, Inc. | MBRX | Elizabeth A. Cermak | Director | appointment | 2026-10-09 |
| AgEagle Aerial Systems Inc. | UAVS | Brent Pope | Chief Operating Officer | retirement | 2026-10-09 |
| Sidus Space Inc. | SIDU | Tiffany Norwood | Director, Audit Committee Chairwoman, and member of the Corporate Governance/Nominating Committee | resignation | 2026-10-09 |
| Sidus Space Inc. | SIDU | Kelle Wendling | Director, member of the Audit Committee, Compensation Committee, and Corporate Governance/Nominating Committee | resignation | 2026-10-09 |
| NextBoat Inc. | NXB | Chad Corbin | Chief Financial Officer | resignation | 2026-10-09 |
| HEALTHEQUITY, INC. | HQY | Michael Fiore | Chief Commercial Officer | departure | 2026-10-09 |
| SELECTIS HEALTH, INC. | GBCS | Clifford L. Neuman | member of the Board of Directors | departure | 2026-10-09 |
| SELECTIS HEALTH, INC. | GBCS | Kent J. Lund | member of the Board of Directors | departure | 2026-10-09 |
| SELECTIS HEALTH, INC. | GBCS | Richard Huebner | member of the Board of Directors | departure | 2026-10-09 |
| SELECTIS HEALTH, INC. | GBCS | Krystal Eckhart | Interim Chief Financial Officer | departure | 2026-10-09 |
| SELECTIS HEALTH, INC. | GBCS | Abraham Schwartz | Director and Officer | appointment | 2026-10-09 |
| SELECTIS HEALTH, INC. | GBCS | Zalman Schapiro | Director and Officer | appointment | 2026-10-09 |
| QUANTUM CORP /DE/ | QMCO | William H. White | Chief Financial Officer and Principal Financial Officer | departure | 2026-10-09 |
| QUANTUM CORP /DE/ | QMCO | Hiral A. Patel | Principal Financial Officer | appointment | 2026-10-09 |
| MITEK SYSTEMS INC | MITK | Michael E. Diamond | Senior Vice President of Sales, Check Verification | departure | 2026-10-09 |
| GOODYEAR TIRE & RUBBER CO /OH/ | GT | Stephen F. Shamrock | Vice President and Controller | appointment | 2026-10-09 |
| Hepion Pharmaceuticals, Inc. | HEPA | Gary Stetz | Chief Financial Officer | appointment | 2026-10-09 |
| Hepion Pharmaceuticals, Inc. | HEPA | Gary Stetz | Interim Chief Executive Officer | departure | 2026-10-09 |
| Hepion Pharmaceuticals, Inc. | HEPA | Sireesh Appajosyula | Chief Executive Officer | appointment | 2026-10-09 |
| TOP Financial Group Ltd | TOP | Dean Huge | Independent Director | appointment | 2026-10-09 |
Yes. TrackSuccession tracks all executive leadership changes at SEC-reporting public companies in real time, covering CEO, CFO, COO, CTO, CMO, General Counsel, board members, and other C-suite roles. It monitors SEC 8-K filings and press releases automatically.
TrackSuccession shows all executive appointments, departures, resignations, and retirements filed today. You can filter by role, sector, company size, and change type.
SEC Form 8-K Item 5.02 requires disclosure of changes in principal officers and directors. This typically includes CEO, CFO, COO, Chief Legal Officer, and board members. TrackSuccession also monitors press releases for roles like CTO, CMO, and EVP that may not require 8-K disclosure.
TrackSuccession has tracked over 13,000 executive leadership changes across 10,000+ SEC-reporting public companies. The volume varies by period but typically runs in the thousands, spanning appointments, departures, retirements, and interim roles.
When a new CEO or CFO is appointed at a public company, it creates a natural outreach moment for law firms, compensation consultants, communications advisors, and other service providers. TrackSuccession gives you the change event, the executive name, and the company details so you can send timely, relevant outreach instead of cold calls.
TrackSuccession lets you track leadership changes at any public company by ticker, sector, or market cap. Corporate strategy and business development teams use this to monitor competitors, customers, suppliers, and M&A targets for C-suite transitions that may signal strategic shifts.
Yes. TrackSuccession provides a searchable, exportable database of executive leadership changes at public companies. Talent intelligence firms and executive recruiters use it to track who moved where, identify newly available executives, and build market maps by sector and role.
Track multiple roles at a company over time in TrackSuccession. Frequent C-suite turnover, multiple departures in a short period, or interim appointments can indicate management instability. PE operating teams, governance investors, and analysts use this pattern as a risk signal.